Detalles de la búsqueda
1.
Severe morbidity and hospital-based mortality from Rift Valley fever disease between November 2017 and March 2020 among humans in Uganda.
Virol J
; 21(1): 104, 2024 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38702807
2.
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial.
PLoS Med
; 19(1): e1003865, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35015777
3.
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.
PLoS Med
; 18(10): e1003813, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34714820
4.
Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus-Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy.
J Infect Dis
; 222(3): 381-390, 2020 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31714954
5.
Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania.
J Infect Dis
; 220(1): 46-56, 2019 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30796818
6.
Uptake of hormonal contraceptives and correlates of uptake in a phase III clinical trial in rural South Western Uganda.
Reprod Health
; 14(1): 36, 2017 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28284221
7.
Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study.
Malar J
; 15: 361, 2016 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27417903
8.
Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory.
EBioMedicine
; 91: 104562, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37099841
9.
Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda.
Vaccine
; 41(50): 7573-7580, 2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37981473
10.
Clinical manifestations of Rift Valley fever in humans: Systematic review and meta-analysis.
PLoS Negl Trop Dis
; 16(3): e0010233, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35333856
11.
NK Cell Subset Redistribution and Antibody Dependent Activation after Ebola Vaccination in Africans.
Vaccines (Basel)
; 10(6)2022 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35746491
12.
Quality of life and associated factors among HIV positive patients after completion of treatment for Cryptococcal meningitis.
PLoS Negl Trop Dis
; 15(3): e0008983, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33657099
13.
Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda.
Glob Health Action
; 13(1): 1829829, 2020 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33073737
14.
Determinants of two-year mortality among HIV positive patients with Cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive dexamethasone in Uganda.
PLoS Negl Trop Dis
; 14(11): e0008823, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33253210
15.
Factors affecting mortality among HIV positive patients two years after completing recommended therapy for Cryptococcal meningitis in Uganda.
PLoS One
; 14(1): e0210287, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30699151
16.
Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial.
PLoS One
; 13(12): e0206907, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30596666
17.
Reasons for participating in a randomised clinical trial: The volunteers' voices in the COSTOP trial in Uganda.
Contemp Clin Trials Commun
; 7: 44-47, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29696167
18.
Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults.
AIDS
; 31(4): 577-582, 2017 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28121670
19.
Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study.
AIDS
; 30(4): 635-44, 2016 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26558729
20.
Exit interviews administered to patients participating in the COSTOP placebo controlled randomised trial in Uganda.
Contemp Clin Trials Commun
; 3: 142-146, 2016 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27536738